October 27, 2015 The 5 most common medications in the US and how to save on them Prescription spending went through the roof in 2014 in the United States.
October 27, 2015 Last-line antibiotics losing ability to kill superbugs in EU Europe faces a growing threat from superbugs that are resistant to a powerful, last-resort class of antibiotics known as carbapenems, the EU's disease monitoring agency said on Friday.
October 27, 2015 Pfizer, FDA in talks on prescription details for key breast cancer drug Pfizer Inc said Thursday it has begun talks with the U.S. Food and Drug Administration to finalize the prescription label of its breast cancer drug palbociclib, in an indication the drug was likely closer to regulatory approval. Â
October 27, 2015 Single yellow fever shot is enough, WHO says The World Health Organization says a yellow fever booster vaccination given 10 years after the initial shot isn't necessary.
October 27, 2015 AIDS drugs halve HIV risk for intravenous drug users in study A daily dose of powerful anti-HIV medicine helped cut the risk of infection with the AIDS virus by 49 percent in intravenous drug users in a Bangkok study that showed for the first time such a preventive step can work in this high-risk population.
October 27, 2015 Top court to hear arguments over generic drugmaker liability The Supreme Court will hear arguments on Tuesday in a case that could decide whether generic drugmakers can be held liable for alleged flaws in the designs of their medications, even though federal law requires generic manufacturers to copy the brand drugmaker's design
October 27, 2015 Vaccine eradicates virus that causes AIDS in monkeys Researchers have reported a major breakthrough in the field of HIV research, claiming they have created a vaccine that completely eradicates the virus that causes AIDS in some monkeys. And the next step? Testing the vaccine in humans.
October 27, 2015 Most countries woefully unprepared to fight resistant superbugs, says WHO Only 34 countries have national plans to fight the global threat of antibiotic resistance, meaning few are prepared to tackle "superbug" infections which put even basic healthcare at risk, the WHO said on Wednesday.
October 27, 2015 FDA approves Glaxo, Theravance's Breo Ellipta asthma drug The U.S. Food and Drug Administration on Thursday approved the sale of Breo Ellipta as a once-daily treatment for asthma in patients aged 18 and older, GlaxoSmithKline and Theravance Inc said.
October 27, 2015 J&J tries new cap to curb fatal Tylenol overdoses Bottles of Tylenol sold in the U.S. will soon bear red warnings alerting users to the potentially fatal risks of taking too much of the popular pain reliever.Â